Insider trades
B. Lynne Parshall, Director of Foghorn Therapeutics FHTX, has filed 0 purchases and 23 sales on the open market. Over the past 12 months that comes to a net sale of $2.2M. The latest trade was on 06/24.
B. Lynne Parshall
Director
- Company
- Foghorn Therapeutics FHTX
- First filing
- 23/05/18
- Trades
- 71 trades
- Buys / sales
- 0 / 23
- 12-month net buying
- −$2.2M
- Last trade
- 06/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
CytokineticsCYTK | Open-market sale10b5-1 plan | 06/01 | 06/01 | 5,000 sh | $74.08 | $370,400 | −24.1% |
| Open-market sale10b5-1 plan | 04/15 | 04/17 | 5,000 sh2 trades | $76.27avg. | $381,366.52 | −8.9% | |
CytokineticsCYTK | Open-market sale10b5-1 plan | 03/02 | 03/02 | 5,000 sh | $61.21 | $306,050 | −21.8% |
| Open-market sale10b5-1 plan | 02/11 | 02/13 | 5,000 sh | $82.72 | $413,600 | −8.2% | |
CytokineticsCYTK | Open-market sale10b5-1 plan | 25/11/19 | 25/11/19 | 5,000 sh | $64.73 | $323,650 | −17.9% |
| Open-market sale10b5-1 plan | 25/10/15 | 25/10/16 | 5,000 sh | $71.74 | $358,700 | −7.5% | |
| Open-market sale10b5-1 plan | 25/09/02 | 25/09/04 | 20,000 sh2 trades | $50.91avg. | $1,018,297.5 | −23.2% | |
| Open-market sale10b5-1 plan | 25/08/06 | 25/08/08 | 5,000 sh2 trades | $41.93avg. | $209,654 | −5.5% | |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/09/09 | 24/09/09 | 5,000 sh | $54.92 | $274,600 | −19.5% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/08/26 | 24/08/26 | 5,000 sh | $57.26 | $286,300 | −19.5% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/08/12 | 24/08/12 | 5,000 sh | $55.20 | $276,000 | −19.5% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/07/29 | 24/07/31 | 5,000 sh | $59.84 | $299,200 | −19.5% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/07/15 | 24/07/16 | 5,000 sh | $55.82 | $279,100 | −19.5% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/07/01 | 24/07/01 | 5,000 sh | $54.22 | $271,100 | −19.5% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/06/17 | 24/06/17 | 5,000 sh | $52.55 | $262,750 | −19.5% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/06/03 | 24/06/04 | 5,000 sh | $48.64 | $243,200 | −24.3% |
| Open-market sale10b5-1 plan | 23/12/26–23/12/28 | 23/12/28 | 117,638 sh3 trades | $50.48avg. | $5,938,144.73 | −58.8% | |
| Open-market sale10b5-1 plan | 23/09/26 | 23/09/28 | 10,000 sh | $45.13 | $451,300 | −10.8% |